<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Dent. Med.</journal-id><journal-title-group>
<journal-title>Frontiers in Dental Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Dent. Med.</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2673-4915</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fdmed.2026.1763201</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Research Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fibronectin-gelatin nanofilm coating improves dental pulp stem cell survival and differentiation in odontogenesis-mimicking organotypic 3D bilayered constructs</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Jimenez-Armijo</surname><given-names>Alexandra</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1288364/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Bugueno</surname><given-names>Isaac Maximiliano</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Jerbaka</surname><given-names>Fadi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Suss</surname><given-names>Eve</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Caravello</surname><given-names>Ga&#x00E9;tan</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Kawczynski</surname><given-names>Marzena</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Arntz</surname><given-names>Youri</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1294538/overview"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Bloch-Zupan</surname><given-names>Agn&#x00E8;s</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/27018/overview" /><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Gribova</surname><given-names>Varvara</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/1268919/overview" /><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Institut de G&#x00E9;n&#x00E9;tique et de Biologie Mol&#x00E9;culaire et Cellulaire (IGBMC), Universit&#x00E9; de Strasbourg</institution>, <city>Illkirch</city>, <country country="fr">France</country></aff>
<aff id="aff2"><label>2</label><institution>Centre de R&#x00E9;f&#x00E9;rence des Maladies Rares Orales et Dentaires, CRMR-O-Rares, H&#x00F4;pitaux Universitaires de Strasbourg (HUS), Fili&#x00E8;re de Sant&#x00E9; TETECOU, ERN CRANIO</institution>, <city>Strasbourg</city>, <country country="fr">France</country></aff>
<aff id="aff3"><label>3</label><institution>Orofacial Development &#x0026; Regeneration Unit, Center of Dental Medicine, Faculty of Medicine, University of Zurich</institution>, <city>Zurich</city>, <country country="ch">Switzerland</country></aff>
<aff id="aff4"><label>4</label><institution>Facult&#x00E9; de Chirurgie Dentaire, Universit&#x00E9; de Strasbourg</institution>, <city>Strasbourg</city>, <country country="fr">France</country></aff>
<aff id="aff5"><label>5</label><institution>Laboratoires de Diagnostic G&#x00E9;n&#x00E9;tique, Institut de G&#x00E9;n&#x00E9;tique M&#x00E9;dicale D&#x2019;Alsace, H&#x00F4;pitaux Universitaires de Strasbourg</institution>, <city>Strasbourg</city>, <country country="fr">France</country></aff>
<aff id="aff6"><label>6</label><institution>Biomaterials and Bioengineering, Inserm UMR_S 1121, CNRS EMR 7003, Universit&#x00E9; de Strasbourg</institution>, <city>Strasbourg</city>, <country country="fr">France</country></aff>
<aff id="aff7"><label>7</label><institution>Acc&#x00E9;l&#x00E9;rateur de Recherche Technologique (ART-ARNm), Inserm US55 and Laboratoire Interdisciplinaire Pour L&#x0027;Innovation et la Recherche en Sant&#x00E9; D&#x0027;Orl&#x00E9;ans (LI2RSO), Th&#x00E9;rapies Innovantes et Nanom&#x00E9;decine, Universit&#x00E9; D&#x2019;Orl&#x00E9;ans</institution>, <city>Orl&#x00E9;ans</city>, <country country="fr">France</country></aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Varvara Gribova <email xlink:href="mailto:varvara.gribova@univ-orleans.fr">varvara.gribova@univ-orleans.fr</email> Agn&#x00E8;s Bloch-Zupan <email xlink:href="mailto:agnes.bloch-zupan@unistra.fr">agnes.bloch-zupan@unistra.fr</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-23"><day>23</day><month>02</month><year>2026</year></pub-date>
<pub-date publication-format="electronic" date-type="collection"><year>2026</year></pub-date>
<volume>7</volume><elocation-id>1763201</elocation-id>
<history>
<date date-type="received"><day>08</day><month>12</month><year>2025</year></date>
<date date-type="rev-recd"><day>20</day><month>01</month><year>2026</year></date>
<date date-type="accepted"><day>27</day><month>01</month><year>2026</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2026 Jimenez-Armijo, Bugueno, Jerbaka, Suss, Caravello, Kawczynski, Arntz, Bloch-Zupan and Gribova.</copyright-statement>
<copyright-year>2026</copyright-year><copyright-holder>Jimenez-Armijo, Bugueno, Jerbaka, Suss, Caravello, Kawczynski, Arntz, Bloch-Zupan and Gribova</copyright-holder><license><ali:license_ref start_date="2026-02-23">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license>
</permissions>
<abstract>
<p>Healthcare professionals, researchers, patients and their families affected by rare diseases face many difficulties during diagnosis. A targeted diagnostic tool, using high-throughput sequencing (NGS) technologies, known as GenoDENT, used to unravel molecular diagnosis behind rare diseases with oral and dental manifestations, enabled the identification of more than 15&#x0025; of variants of unknown significance (Class III - VUS), beside a high 70&#x0025;&#x2013;80&#x0025; diagnostic rate in the analyzed patients&#x2019; cohort. VUS make diagnosis more difficult because they prevent precise correlation between genotype and phenotype. To overcome this issue, we are developing 3D <italic>in vitro</italic> models mimicking odontogenesis. Our first 3D models, made of odontoblast-like and ameloblast-like cells, were effective when using murine cells. They were stable over time and showed a good distinction between both used cell types. However, the formation of 3D models from human cells was less efficient, so we decided to couple the 3D model formation technique with the cell-accumulation method to produce stable 3D constructs. This process consists in covering the cells with a biomimetic artificial matrix made of fibronectin (FN) and gelatin (G). We found that FN/G coating improved viability of human dental pulp stem cells (hDPSC) in thick constructs and promoted odontoblast differentiation of hDPSC. In peripheral ameloblast-like cells, ameloblast-associated proteins such as amelogenin were detected in close contact with the odontoblast-like core. We believe that our model can be further modified to introduce patient-specific variations through gene-editing techniques like CRISPR/Cas9, for further development of new diagnostic tools applied to rare oro-dental diseases.</p>
</abstract>
<kwd-group>
<kwd>3D models</kwd>
<kwd>extracellular matrix</kwd>
<kwd>layer-by-layer</kwd>
<kwd>odontogenesis</kwd>
<kwd>rare diseases</kwd>
</kwd-group><funding-group><funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was supported by grant from ANR 2023 &#x201C;Agence Nationale de la Recherche,&#x201D; project: 3DBioDENT 2023 ANR-23-CE17-0048-01, as well as Fondation FORCE 2023-2026 and Impulsion recherche Fili&#x00E8;re TETE COU 2020. We acknowledge the support of the Light Microscopy platform at the IGBMC imaging center, member of the national infrastructure France-BioImaging supported by the French National Research Agency (ANR-10-INBS-04).</funding-statement></funding-group><counts>
<fig-count count="4"/>
<table-count count="0"/><equation-count count="0"/><ref-count count="15"/><page-count count="9"/><word-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Dental Materials</meta-value></custom-meta></custom-meta-group>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><title>Introduction</title>
<p>Healthcare professionals, researchers, people affected by rare diseases and their families face significant diagnostic challenges. This is the case for individuals affected by rare genetic diseases encompassing developmental dental anomalies like enamel defects in amelogenesis imperfecta (AI) and dentin abnormalities in dentinogenesis imperfecta (DI)/dentin dysplasia (DD).</p>
<p>Recently, a targeted genetic study on rare diseases with oral manifestations, using high-throughput sequencing technologies (GenoDENT (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>), has allowed the identification of numerous pathogenic genetic variants (&#x003E;70&#x0025; of positive diagnostic yield), but also numerous variants of unknown significance (VUS) (<xref ref-type="bibr" rid="B1">1</xref>). The potential pathogenicity and functional impact of these VUS remain uncertain, rendering genetic diagnosis difficult. In this context, <italic>in vitro</italic> models of odontoblast-like and ameloblast-like cells carrying mutations (e.g., engineered using CRISPR-Cas9 technology) can be used to unravel the pathogenicity of VUS during amelogenesis and dentinogenesis. Three-dimensional (3D) models are of particular interest, since odontogenesis takes place in a 3D environment.</p>
<p>Tissue engineering is a powerful approach that associates cells with materials to generate tissues for various applications, from fundamental studies to tissue replacement (<xref ref-type="bibr" rid="B4">4</xref>). In the field of dental research, tooth regeneration is a key challenge, and several models are currently available (<xref ref-type="bibr" rid="B5">5</xref>). However, human odontogenesis models are rare and are usually constructed using only one cell type (<xref ref-type="bibr" rid="B6">6</xref>). Thus, RNA expression levels of epithelial cell markers, dental epithelial cell markers, and ameloblast markers significantly increased in hiPSC-derived ameloblast organoids as compared to 2D cultures (<xref ref-type="bibr" rid="B7">7</xref>). In another study,induced early ameloblast organoids were co-cultured with primary human dental pulp stem cells (hDPSC) to assess the interaction level between the two cell types and the effects on ameloblast maturation (<xref ref-type="bibr" rid="B8">8</xref>). This co-culture in suspension could induce AMELX expression in ameloblast organoids and induce strong DSPP expression in the odontoblast organoids. In a recent work, our team described the construction of organotypic 3D bilayered constructs made of odontoblast-like and ameloblast-like cells to mimic odontogenesis and more particularly the late bell stage (<xref ref-type="bibr" rid="B9">9</xref>). At this point, differentiated odontoblasts secrete an extracellular matrix mainly composed of type I collagen, known as pre-dentin. At the same time, pre-ameloblasts come into direct contact with the pre-dentin and the odontoblasts, and differentiate into ameloblasts that deposit enamel matrix proteins such as amelogenin. The method was efficient for murine cells, with a good distinction between the two cell types and good stability of the models over time. However, the formation of the constructs from human cells was less efficient: the constructs were disorganized and demonstrated reduced cell-cell adhesion (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>In this new study, we applied the cell-accumulation method (<xref ref-type="bibr" rid="B10">10</xref>) to cultures of human dental pulp stem cells (hDPSC)-derived 3D constructs for the first time. We verified fibronectin and gelatin (FN/G) coating deposition and evaluated cell viability in 3D constructs made of FN/G-coated hDPSC before differentiating them into odontoblast-like cells and adding ameloblast-like cells to create organotypic 3D bilayered constructs mimicking the late bell stage cytodifferentiation of odontogenesis.</p>
</sec>
<sec id="s2" sec-type="methods"><title>Materials and methods</title>
<sec id="s2a"><title>Cell culture</title>
<p>Human Dental Pulp Stem Cells (hDPSC) are multipotent stem cells harvested from soft living pulp tissue inside adult teeth. hDPSC were provided (courtesy of Dr. Petros Papagerakis, from The University of Saskatchewan, Canada). The cells were grown in &#x03B1;MEM medium&#x2009;&#x002B;&#x2009;GlutaMAX-I with 1&#x2005;g/L of D-glucose and sodium pyruvate (Gibco, Thermo Fisher Scientific, Illkirch-Graffenstaden, France), supplemented with 15&#x0025; fetal calf serum (FCS) and 100&#x2005;U/mL penicillin and 100&#x2005;mg/mL of streptomycin (this medium will be further referred to as GM) at 37&#x00B0;C in a humid environment with 5&#x0025; CO<sub>2</sub>. These cells were further differentiated into odontoblast-like cells in the organotypic constructs. Human ameloblast-like cells were initially characterized as ameloblastoma cells (AM-1) and were originally obtained from a 20-year-old female, immortalized with HPV-16 vector, and clone selection was performed with 1&#x2005;mg/mL G418. Cells were provided by Dr. Sylvie Babajko and Prof. Ariane Berdal (UMR-S 1333 Sant&#x00E9; Orale, Universite Paris Cit&#x00E9;, and, Physiopathological basis of skeletal dysplasia, Universit&#x00E9; Paris Cit&#x00E9;, Inserm UMR-S 1163-IHU Imagine, Paris, France) and were grown in Keratinocyte SFM medium (Thermo Fisher Scientific, Illkirch-Graffenstaden, France) complemented with 1&#x2005;mg/mL G418 (Roche) for clone selection and 50&#x2005;&#x03BC;g/mL of Gentamicin at 37&#x00B0;C in a humidified atmosphere with 5&#x0025; CO<sub>2</sub>.</p>
</sec>
<sec id="s2b"><title>2D cell cultures immunofluorescence</title>
<p>Immunofluorescence on 2D cell cultures was performed at room temperature after plating hDPSC and AM1 in a 24 well-plate (5&#x2009;&#x00D7;&#x2009;10<sup>4</sup>&#x2005;cells/well) and fixing with PFA 4&#x0025;. Following a 15&#x2005;min PBS-Tween 0.2&#x0025; treatment, cells were incubated with Bovine serum albumin (BSA) 0.5&#x0025; and Triton X-100 0.1&#x0025; solution in PBS (PBS-BT) for 15&#x2005;min. Antibodies (primary: COL1A1: mouse anti-human, Santa Cruz, sc-293182, dilution 1/100; DSPP: rabbit anti-human, Bioss, bs-10316R, dilution 1/200; FAM83H: rabbit anti-human, Invitrogen, PA5&#x2013;55094, dilution 1/100; AMELX: mouse anti-human, Santa Cruz, sc-365284, dilution 1/100; secondary: Alexa Fluor 488, donkey anti-mouse IgG ThermoFisher, A-21202, dilution 1/200; Alexa Fluor 488, donkey anti-rabbit IgG, ThermoFisher, A-21206, dilution 1/250) were incubated for 1&#x2005;h, followed by incubation in phalloidin 1/1000 in PBS-1&#x0025; BSA solution for 15&#x2005;min. Finally, one drop 1&#x2005;&#x00B5;g/mL of 4&#x2032;,6-diamidino-2-phenylindole (DAPI) solution was added to each slide. The slides were observed using Leica Dmi 8&#x2009;&#x002B;&#x2009;Yokogawa CSU W1 - ILAS2 confocal microscope.</p>
</sec>
<sec id="s2c"><title>Fabrication of 3D structures</title>
<p>The cells were detached from culture dishes using trypsin 0.25&#x0025; EDTA 0.02&#x0025; and washed with GM. The coating was performed as previously described (<xref ref-type="bibr" rid="B3">3</xref>). Briefly, the cells were resuspended in Tris-HCl buffer (Tris-HCl 50&#x2005;mM pH 7.4) and subsequently incubated for 1&#x2005;min with 0.04&#x2005;mg/mL FN, G (Sigma-Aldrich) solutions in Tris-HCl buffer or with Tris-HCl buffer alone (rinsing step). To remove the solutions, the cells were centrifuged at 200&#x2005;g for 1&#x2005;min, and the supernatant was removed. After (FN/G)<sub>4</sub>FN nanofilms were formed, the cells were resuspended in GM at a desired concentration.</p>
</sec>
<sec id="s2d"><title>Coating validation</title>
<p>To verify the deposition of (FN/G)<sub>4</sub>FN nanofilms onto the cells, 5&#x2009;&#x00D7;&#x2009;10<sup>4</sup> cells were deposited into a 24-well insert with a semipermeable membrane (Corning 3470, 0.4 &#x03BC;m pore size) and placed into 24-well plates. One milliliter of GM was added in a 24-well plate outside the inserts. The cells were incubated for 4&#x2005;h at 37&#x2005;&#x00B0;C, and then another 1&#x2005;mL of GM was added to the 24-well plate to connect the media between the inside and the outside of the insert. After 24&#x2005;h the medium was removed and the cells were fixed with 4&#x0025; PFA, then stained for FN (primary antibody: 1/200 rabbit anti-human, Sigma-Aldrich, F3648, secondary antibody: 1/250 Alexa Fluor 488, donkey anti-rabbit IgG, ThermoFisher, A-21206), actin, and nuclei as previously described (<xref ref-type="bibr" rid="B4">4</xref>). To assess the viability of the coated cells, 10<sup>5</sup>, 2.5&#x2009;&#x00D7;&#x2009;10<sup>5</sup> cells were deposited into the inserts coated with 100&#x2005;&#x03BC;l of 0.04&#x2005;mg/mL FN at 37&#x00B0;C for 30&#x2005;min, cultured for 4 days in GM, and submitted to Live/Dead staining according to the manufacturer&#x0027;s instructions (<xref ref-type="fig" rid="F1">Figure&#x00A0;1A</xref>).</p>
<fig id="F1" position="float"><label>Figure&#x00A0;1</label>
<caption><p>Organoid formation yand sample preparation. <bold>(A)</bold> Sample preparation for fibronectin/gelatin (FN/G) coating verification and cell viability assessment. <bold>(B)</bold> Organoid preparation from (FN/G)<sub>4</sub>FN-coated human dental pulp stem cells (hDPSC) and AM-1 ameloblast-like cells. <bold>(C)</bold> Organoid preparation timeline. GM, growth medium; DM, differentiation medium; K-SFM, keratinocyte serum-free medium. <bold>(D)</bold> Organoid sample preparation for fluorescent labeling.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fdmed-07-1763201-g001.tif"><alt-text content-type="machine-generated">Four-panel infographic depicting hDPSC cell coating and differentiation procedures: Panel A shows sequential fibronectin and gelatin coating with FN staining and viability testing; panel B shows coating, 3D organoid formation and differentiation in low-adhesion plates with AM-1 treatment; panel C presents a timeline of hDPSC differentiation to odontoblast-like cells with media changes; panel D illustrates cryosectioning of organoids into thin slices for glass slide analysis.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2e"><title>3D cellular organotypic culture and immunofluorescence</title>
<p>3D construct formation was performed using ultra-low attachment plates (PrimeSurface&#x00AE; 96V-shaped bottom, S-bio, Japan). First, odontoblast-like cells were cultured at a concentration of 5&#x2009;&#x00D7;&#x2009;10<sup>3</sup>&#x2005;cells/well for 7 days in GM to allow cell attachment, then for 15 days in differentiation medium (DM). The differentiation medium was composed of the GM supplemented with 0.1 M dexamethasone, 5&#x2005;mM glycerophosphate, 50&#x2005;mg/mL ascorbic acid, and 10&#x2005;ng/mL TGF-&#x03B2;1, all from Sigma-Aldrich (Merck, Darmstadt, Land de Hesse, Germany). At day 22, ameloblast-like cells were added into the wells containing differentiated odontoblast constructs at a concentration of 3&#x2009;&#x00D7;&#x2009;10<sup>3</sup> cells per well and were incubated for 7 more days, ending at day 29 (<xref ref-type="fig" rid="F1">Figures&#x00A0;1B,C</xref>). Next, the resulting structures were fixed using 4&#x0025; PFA, then incorporated into a block of Epredia&#x2122; Cryomatrix&#x2122; and placed at &#x2212;80&#x00B0;C to freeze. The block was then cut with a cryostat, and 25&#x2005;&#x00B5;m sections were deposited on glass slides for fluorescent staining (<xref ref-type="fig" rid="F1">Figure&#x00A0;1D</xref>).</p>
<p>For fluorescent staining of organoids sections, they were first treated with Triton X-100 0.1&#x0025; in PBS for 15&#x2005;min, then saturated with 0.1&#x0025; BSA for 1&#x2005;h, then incubated with primary and secondary antibodies (primary: COL1A1: mouse anti-human, Santa Cruz, sc-293182, dilution 1/100; DSPP: rabbit anti-human, Bioss, bs-10316R, dilution 1/200; FAM83H: rabbit anti-human, Invitrogen, PA5-55094, dilution 1/100; AMELX: mouse anti-human, Santa Cruz, sc-365284, dilution 1/100; secondary: Alexa Fluor 488, donkey anti-mouse IgG ThermoFisher, A-21202, dilution 1/200; Alexa Fluor 488, donkey anti-rabbit IgG, ThermoFisher, A-21206, dilution 1/250; Alexa Fluor 568, donkey anti-rabbit IgG, ThermoFisher, A-10042, dilution 1/200; Alexa Fluor 568, donkey anti-mouse IgG, ThermoFisher, A-10037, dilution 1/250) for 1&#x2005;h and 30&#x2005;min, respectively, and rinsed 3 times with PBS after each step. ProLong&#x2122; Diamond antifade reagent (Molecular Probes) was used for mounting. Mounted slides were observed with the Leica Dmi 8&#x2009;&#x002B;&#x2009;Yokogawa CSU W1&#x2014;ILAS2 confocal microscope.</p>
</sec>
<sec id="s2f"><title>Data analysis and statistics</title>
<p>Fibronectin labeling and cell viability experiment were performed 2 times, two samples per experimental condition. Cell viability values correspond to the average number of dead cells per image quantified from 10 images, and the error bars to standard deviation. Organotypic 3D construct culture and immunofluorescence results correspond to 3 independent experiments, 10 constructs per experimental condition. Odontoblast core diameter was quantified from 5 images, an average of 10 diameters measured using ImageJ software (v1.44p, NIH, Bethesda, US) was calculated. Data are reported as means &#x00B1; standard deviation. Student&#x0027;s t-test was performed to compare coated and uncoated samples. Statistical significance was set at <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><title>Results</title>
<sec id="s3a"><title>FN/G coating maintain the viability of hDPSC in 3D cellular structures</title>
<p>The cell-accumulation method, which consists of cell coating with FN/G nanomatrix, was developed by the group of Prof. Akashi and applied to different cell types, including human dermal fibroblasts (<xref ref-type="bibr" rid="B10">10</xref>), skeletal muscle progenitors (<xref ref-type="bibr" rid="B11">11</xref>) and hepatocytes (<xref ref-type="bibr" rid="B12">12</xref>). Here, we used it for the first time to coat hDPSC cells. The results showed the presence of FN network in monolayer samples of hDPSC coated with (FN/G)<sub>4</sub>FN (<xref ref-type="fig" rid="F2">Figure&#x00A0;2A</xref>). Some FN can also be detected in uncoated samples, but in much lower quantities. This corresponds to the FN secreted by the cells.</p>
<fig id="F2" position="float"><label>Figure&#x00A0;2</label>
<caption><p>Fibronectin/gelatin (FN/G) coating and viability in 3D constructs. <bold>(A)</bold> FN (green), actin (red) and nuclei (blue) staining. Scale bar: 20&#x2005;&#x00B5;m. <bold>(B)</bold> Live(green)/Dead (red) staining, scale bar: 100&#x2005;&#x00B5;m. <bold>(C)</bold> Quantification of dead cells per image, &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fdmed-07-1763201-g002.tif"><alt-text content-type="machine-generated">Panel A shows fluorescence microscopy images comparing FN/G-coated and non-coated surfaces, with cells stained for actin in red, ECM in green, and nuclei in blue. Panel B presents cell viability images for two seeding densities, highlighting fewer dead cells (red) on FN/G-coated surfaces. Panel C contains a bar graph quantifying dead cells per image, showing significantly fewer dead cells on FN/G-coated versus non-coated surfaces at higher cell density, indicated by an asterisk for statistical significance.</alt-text>
</graphic>
</fig>
<p>Next, we tested cell viability in two types of constructs of different thickness (10<sup>5</sup> or 2.5&#x2009;&#x00D7;&#x2009;10<sup>5</sup> cells seeded into the inserts, as indicated in the <xref ref-type="fig" rid="F1">Figure&#x00A0;1A</xref>) and found that (FN/G)<sub>4</sub>FN coating improved viability in thicker constructs (<xref ref-type="fig" rid="F2">Figure&#x00A0;2B</xref>), leading to a significant decrease in the number of dead cells compared to uncoated samples (<xref ref-type="fig" rid="F2">Figure&#x00A0;2C</xref>). These results demonstrate the importance of the cell environment for cell survival in 3D constructs and indicate that FN/G coating is appropriate to maintain the viability of hDPSC in 3D structures.</p>
</sec>
<sec id="s3b"><title>Human ameloblast-like cells and dental pulp stem cells express amelogenesis and odontogenesis-associated proteins</title>
<p>The basic level of expression of proteins associated with amelogenesis and odontogenesis was first assessed in 2D cultures. Type I collagen (COL1) forms most of the organic material (&#x223C;85&#x0025;) in dentin, and dentin sialophosphoprotein (DSPP) is the most abundant non-collagenous protein in dentin (<xref ref-type="bibr" rid="B13">13</xref>). Amelogenin (AMELX) is the main enamel matrix protein, and Family with Sequence Similarity 83 Member H (FAM83H) has a role in the structural development and mineralization of enamel (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). The results showed expression of these proteins in 2D cultures of AM-1 (ameloblast-like cells) and hDPSC (<xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>), indicating that the cells were appropriate to use for formation of bilayered organoids mimicking odontogenesis. More detailed characterization of the cell types can be found in our previous work (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<fig id="F3" position="float"><label>Figure&#x00A0;3</label>
<caption><p>Cell morphology and protein expression in human dental pulp stem cells and ameloblast-like cells (AM1). <bold>(A)</bold> Immunofluorescent labeling in ameloblast-like cells AM-1 for amelogenin (AMELX) and FAM83H [<bold>(A)</bold>, green] and in human dental pulp stem cells for DSP-1 domain (DSP) and COL1A1 [<bold>(B)</bold>, green]. Actin is labelled in red (phalloidin) and nuclei in blue (DAPI). Scale bars are represented in each caption. For each immunofluorescence (IF) image, all channels are presented separately.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fdmed-07-1763201-g003.tif"><alt-text content-type="machine-generated">Panel A shows illustrations, light microscopy, and fluorescent images of human ameloblast-like cells, featuring stained nuclei, actin filaments, and specific protein markers in blue, red, and green. Panel B presents illustrations, light microscopy, and fluorescent images of human dental pulp stem cells, with similar color-coded stains highlighting cell nuclei, actin filaments, and protein markers, showing distinct cellular morphologies and organization.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c"><title>FN/G coating favorizes odontogenic differentiation of hDPSC and gives more stability in 3D</title>
<p>Organotypic 3D bilayered construct formation from hDPSC and AM-1 cells was monitored day by day; selected time points are presented in <xref ref-type="fig" rid="F4">Figure&#x00A0;4A</xref>. At Day 1 in GM, some differences are visible between the samples, but they disappear by Day 4. At Day 13, in DM, the structures appear dense, which is probably due to the mineralization of the hDPSC during differentiation. Finally, after AM-1 addition, at Day 4 AM-1, bilayered structures can be observed, with a denser odontoblast-based core and semi-transparent AM-1 layer (<xref ref-type="fig" rid="F4">Figure&#x00A0;4A</xref>).</p>
<fig id="F4" position="float"><label>Figure&#x00A0;4</label>
<caption><p>Organotypic 3D model construction and differentiation. <bold>(A)</bold> Phase contrast microscopy observation of bilayered construct formation from human dental pulp stem cells (hDPSC) and AM-1 cells in growth medium (GM) or under odontogenic differentiation conditions (DM). Scale bar&#x2009;&#x003D;&#x2009;50&#x2005;&#x00B5;m. <bold>(B)</bold> Fluorescent labeling of bilayered construct cross-sections (7 days of hDPSC culture in GM, followed by 15 days in DM and 7 days of co-culture with AM-1). Scale bar&#x2009;&#x003D;&#x2009;100&#x2005;&#x00B5;m. <bold>(C)</bold> Quantification of the odontoblast-core diameter, &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01. <bold>(D)</bold> Visualization of odontoblasts and ameloblast interactions. Fluorescent labeling for amelogenin (AMELX, red), dentin sialophosphoprotein (DSPP, green) and nuclei (blue) of bilayered construct cross-sections (7 days of human dental pulp stem cell culture in growth medium, followed by 15 days in odontogenic differentiation medium and 7 days of co-culture with AM-1). Scale bar&#x2009;&#x003D;&#x2009;100&#x2005;&#x00B5;m (upper images).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fdmed-07-1763201-g004.tif"><alt-text content-type="machine-generated">Panel A shows light microscopy images of cellular spheroids under FN/G-coated and non-coated (NC) conditions across different stages and media, with shape and size variations evident. Panel B displays fluorescent immunostaining of spheroids for COL1A1 in green, FAM83H in red, and cell nuclei in blue, comparing FN/G-coated and non-coated samples. Panel C presents a bar graph quantifying core diameter, showing significantly larger diameters in FN/G-coated spheroids. Panel D features fluorescent images stained for DSPP in green, AMELX in red, and nuclei in blue, highlighting differences in marker localization and abundance between FN/G-coated and non-coated spheroid sections.</alt-text>
</graphic>
</fig>
<p>Fluorescent staining of odontoblast and ameloblast markers, COL1A1/DSPP and FAM83H/AMELX, respectively, allowed to visualize odontoblast core and the surrounding ameloblast layer in 3D construct cross-sections (<xref ref-type="fig" rid="F4">Figures&#x00A0;4B,D</xref>). The odontoblast core was significantly larger in FN/G-coated samples (<xref ref-type="fig" rid="F4">Figure&#x00A0;4C</xref>), suggesting that FN/G coating was favorable for odontogenic differentiation of hDPSC, making the core more stable over the 1-month culture. These results are in accordance with the observations using phase contrast: while some degradation of organoids could be observed in uncoated samples, FN/G-coated samples remained unaffected (data not shown).</p>
<p>The epithelial ameloblast-associated protein FAM83H showed robust staining in the ameloblast-like cell layer (<xref ref-type="fig" rid="F4">Figure&#x00A0;4B</xref>) in both non-coated and FN/G-coated samples. While no difference of protein expression was visually observed, the variation has been detected at mRNA level (<xref ref-type="sec" rid="s11">Supplementary Table S1</xref>; <xref ref-type="sec" rid="s11">Supplementary Figure S1</xref>), with a 3-fold increase in <italic>FAM83H</italic> expression in FN/G-coated samples compared to non-coated samples, indicating that a well-differentiated and stable odontoblast core is favorable for <italic>FAM83H</italic> expression.</p>
<p>AMELX protein expression was observed in both non-coated and FN/G-coated samples. However, while it was randomly distributed in AM-1 cell layer in non-coated samples, in FN/G-coated samples it was mostly localized in contact with the odontoblast core (<xref ref-type="fig" rid="F4">Figure&#x00A0;4D</xref>, arrows), which reflects what happens <italic>in vivo</italic> during odontogenesis: during enamel maturation, ameloblasts attach to the dentin surface (<xref ref-type="bibr" rid="B13">13</xref>). Precise molecular mechanisms of epithelio-mesenchymal crosstalk during tooth formation are difficult to study <italic>in vitro</italic> using 2D cell culture, therefore the development of appropriate 3D odontogenesis models can help to better understand these processes. In the study by Alghadeer et al. AMELX and ENAM were visualized at the interface between 3D co-cultured human iPSC-derived epithelial organoids and hDPSC (<xref ref-type="bibr" rid="B8">8</xref>). Here, we propose a different 3D system with a stable odontoblast-like core, a surrounding ameloblast-like layer and AMELX expression at the interface. As AMELX localized expression is very challenging to precisely quantify, we present only qualitative imaging results in the present work. In the future, 3D construct permeabilization will be applied to image odontoblast-ameloblast interactions in 3D and provide quantitative results. In addition, different batches of hDPSC could be tested to evaluate the potential variability between hDPSC from different donors. Another limitation of our study concerns using immortalized AM-1 cells, which could be replaced by human-induced pluripotent stem cells (hiPSCs) differentiated into human dental epithelial cells using established protocol (<xref ref-type="bibr" rid="B7">7</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="conclusions"><title>Conclusion</title>
<p>In the present study, we employed, for the first time, FN/G-coated hDPSC that were used to form organotypic 3D bilayered structures with AM-1 ameloblast-like cells after odontoblastic differentiation of hDPSC. The results emphasize the importance of the cell environment for cell viability in 3D cultures, as well as for long-term 3D culture stability. This relatively easy to construct model can become an organotypic platform for studying odontogenic differentiation in the context of rare oro-dental diseases, for instance to study patient-specific variations after gene editing to improve diagnostics.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability"><title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6" sec-type="ethics-statement"><title>Ethics statement</title>
<p>Ethical approval was not required for the studies involving humans because the samples were donated from another research group. The studies were conducted in accordance with the local legislation and institutional requirements. The human samples used in this study were acquired from gifted from another research group. Written informed consent to participate in this study was not required from the participants or the participants&#x2019; legal guardians/next of kin in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions"><title>Author contributions</title>
<p>AJ-A: Investigation, Supervision, Writing &#x2013; review &#x0026; editing. IB: Conceptualization, Funding acquisition, Methodology, Supervision, Writing &#x2013; review &#x0026; editing. FJ: Investigation, Writing &#x2013; review &#x0026; editing. ES: Investigation, Writing &#x2013; review &#x0026; editing. GC: Writing &#x2013; review &#x0026; editing. MK: Writing &#x2013; review &#x0026; editing. YA: Funding acquisition, Writing &#x2013; review &#x0026; editing. AB-Z: Conceptualization, Funding acquisition, Project administration, Supervision, Writing &#x2013; review &#x0026; editing. VG: Conceptualization, Investigation, Methodology, Supervision, Writing &#x2013; original draft.</p>
</sec>
<ack><title>Acknowledgments</title>
<p>We thank Dr Yann H&#x00E9;rault for the fruitful discussions.</p>
</ack>
<sec id="s9" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author AB-Z declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s10" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s12" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material"><title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fdmed.2026.1763201/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fdmed.2026.1763201/full&#x0023;supplementary-material</ext-link></p>
<supplementary-material xlink:href="Datasheet1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloch-Zupan</surname> <given-names>A</given-names></name> <name><surname>Rey</surname> <given-names>T</given-names></name> <name><surname>Jimenez-Armijo</surname> <given-names>A</given-names></name> <name><surname>Kawczynski</surname> <given-names>M</given-names></name> <name><surname>Kharouf</surname> <given-names>N</given-names></name><collab>, O-Rare consortium</collab><etal/></person-group> <article-title>Amelogenesis imperfecta: next-generation sequencing sheds light on witkop&#x2019;s classification</article-title>. <source>Front Physiol</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1130175</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2023.1130175</pub-id><pub-id pub-id-type="pmid">37228816</pub-id></mixed-citation></ref>
<ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rey</surname> <given-names>T</given-names></name> <name><surname>Tarabeux</surname> <given-names>J</given-names></name> <name><surname>Gerard</surname> <given-names>B</given-names></name> <name><surname>Delbarre</surname> <given-names>M</given-names></name> <name><surname>Le Béchec</surname> <given-names>A</given-names></name> <name><surname>Stoetzel</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Protocol GenoDENT: implementation of a new NGS panel for molecular diagnosis of genetic disorders with orodental involvement</article-title>. <source>Methods Mol Biol</source>. (<year>2019</year>) <volume>1922</volume>:<fpage>407</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-9012-2_36</pub-id><pub-id pub-id-type="pmid">30838594</pub-id></mixed-citation></ref>
<ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname> <given-names>MK</given-names></name> <name><surname>Geoffroy</surname> <given-names>V</given-names></name> <name><surname>Vicaire</surname> <given-names>S</given-names></name> <name><surname>Jost</surname> <given-names>B</given-names></name> <name><surname>Dumas</surname> <given-names>M</given-names></name> <name><surname>Le Gras</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>A targeted next-generation sequencing assay for the molecular diagnosis of genetic disorders with orodental involvement</article-title>. <source>J Med Genet</source>. (<year>2016</year>) <volume>53</volume>(<issue>2</issue>):<fpage>98</fpage>&#x2013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103302</pub-id><pub-id pub-id-type="pmid">26502894</pub-id></mixed-citation></ref>
<ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esdaille</surname> <given-names>CJ</given-names></name> <name><surname>Washington</surname> <given-names>KS</given-names></name> <name><surname>Laurencin</surname> <given-names>CT</given-names></name></person-group>. <article-title>Regenerative engineering: a review of recent advances and future directions</article-title>. <source>Regen Med</source>. (<year>2021</year>) <volume>16</volume>(<issue>5</issue>):<fpage>495</fpage>&#x2013;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.2217/rme-2021-0016</pub-id><pub-id pub-id-type="pmid">34030463</pub-id></mixed-citation></ref>
<ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W</given-names></name> <name><surname>Yelick</surname> <given-names>PC</given-names></name></person-group>. <article-title>Tooth repair and regeneration: potential of dental stem cells</article-title>. <source>Trends Mol Med</source>. (<year>2021</year>) <volume>27</volume>(<issue>5</issue>):<fpage>501</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2021.02.005</pub-id><pub-id pub-id-type="pmid">33781688</pub-id></mixed-citation></ref>
<ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>H-Y</given-names></name> <name><surname>Cooley</surname> <given-names>V</given-names></name> <name><surname>Kim</surname> <given-names>E-J</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Lee</surname> <given-names>J-M</given-names></name> <name><surname>Sheyfer</surname> <given-names>D</given-names></name><etal/></person-group> <article-title>Adult dental epithelial stem cell-derived organoids deposit hydroxylapatite biomineral</article-title>. <source>Int. J. Oral Sci</source>. (<year>2023</year>) <volume>15</volume>(<issue>1</issue>):<fpage>55</fpage>. <pub-id pub-id-type="doi">10.1038/s41368-023-00257-w</pub-id><pub-id pub-id-type="pmid">38062012</pub-id></mixed-citation></ref>
<ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>K-H</given-names></name> <name><surname>Kim</surname> <given-names>E-J</given-names></name> <name><surname>Kim</surname> <given-names>H-Y</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Jung</surname> <given-names>H-S</given-names></name></person-group>. <article-title>Fabrication of functional ameloblasts from hiPSCs for dental application</article-title>. <source>Front Cell Dev Biol</source>. (<year>2023</year>) <volume>11</volume>:<fpage>1164811</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2023.1164811</pub-id><pub-id pub-id-type="pmid">37457296</pub-id></mixed-citation></ref>
<ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alghadeer</surname> <given-names>A</given-names></name> <name><surname>Hanson-Drury</surname> <given-names>S</given-names></name> <name><surname>Patni</surname> <given-names>AP</given-names></name> <name><surname>Ehnes</surname> <given-names>DD</given-names></name> <name><surname>Zhao</surname> <given-names>YT</given-names></name> <name><surname>Li</surname> <given-names>Z</given-names></name><etal/></person-group> <article-title>Single-Cell census of human tooth development enables generation of human enamel</article-title>. <source>Dev Cell</source>. (<year>2023</year>) <volume>58</volume>(<issue>20</issue>):<fpage>2163</fpage>&#x2013;<lpage>80.e9</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2023.07.013</pub-id><pub-id pub-id-type="pmid">37582367</pub-id></mixed-citation></ref>
<ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jerbaka</surname> <given-names>F</given-names></name> <name><surname>Gribova</surname> <given-names>V</given-names></name> <name><surname>Rey</surname> <given-names>T</given-names></name> <name><surname>Elfaloussi</surname> <given-names>S</given-names></name> <name><surname>Kawczynski</surname> <given-names>M</given-names></name> <name><surname>Kharouf</surname> <given-names>N</given-names></name><etal/></person-group> <article-title>Organotypic 3D cellular models mimicking the epithelio-ectomesenchymal bilayer during odontogenesis</article-title>. <source>Tissue Eng Part A</source>. (<year>2025</year>) <volume>31</volume>(<issue>11-12</issue>):<fpage>471</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tea.2024.0118</pub-id><pub-id pub-id-type="pmid">39276088</pub-id></mixed-citation></ref>
<ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiguchi</surname> <given-names>A</given-names></name> <name><surname>Yoshida</surname> <given-names>H</given-names></name> <name><surname>Matsusaki</surname> <given-names>M</given-names></name> <name><surname>Akashi</surname> <given-names>M</given-names></name></person-group>. <article-title>Rapid construction of three-dimensional multilayered tissues with endothelial tube networks by the cell-accumulation technique</article-title>. <source>Adv Mater</source>. (<year>2011</year>) <volume>23</volume>(<issue>31</issue>):<fpage>3506</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1002/adma.201101787</pub-id><pub-id pub-id-type="pmid">21728193</pub-id></mixed-citation></ref>
<ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gribova</surname> <given-names>V</given-names></name> <name><surname>Liu</surname> <given-names>CY</given-names></name> <name><surname>Nishiguchi</surname> <given-names>A</given-names></name> <name><surname>Matsusaki</surname> <given-names>M</given-names></name> <name><surname>Boudou</surname> <given-names>T</given-names></name> <name><surname>Picart</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Construction and myogenic differentiation of 3D myoblast tissues fabricated by fibronectin-gelatin nanofilm coating</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>2016</year>) <volume>474</volume>(<issue>3</issue>):<fpage>515</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.04.130</pub-id><pub-id pub-id-type="pmid">27125461</pub-id></mixed-citation></ref>
<ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuzawa</surname> <given-names>A</given-names></name> <name><surname>Matsusaki</surname> <given-names>M</given-names></name> <name><surname>Akashi</surname> <given-names>M</given-names></name></person-group>. <article-title>Construction of three-dimensional liver tissue models by cell accumulation technique and maintaining their metabolic functions for long-term culture without medium change</article-title>. <source>J Biomed Mater Res A</source>. (<year>2015</year>) <volume>103</volume>(<issue>4</issue>):<fpage>1554</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.35292</pub-id><pub-id pub-id-type="pmid">25088964</pub-id></mixed-citation></ref>
<ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamakoshi</surname> <given-names>Y</given-names></name></person-group>. <article-title>Dentin sialophosphoprotein (DSPP) and dentin</article-title>. <source>J Oral Biosci</source>. (<year>2008</year>) <volume>50</volume>(<issue>1</issue>):<fpage>33</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/S1349-0079(08)80016-3</pub-id><pub-id pub-id-type="pmid">20037676</pub-id></mixed-citation></ref>
<ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname> <given-names>JT</given-names></name></person-group>. <article-title>Enamel phenotypes: genetic and environmental determinants</article-title>. <source>Genes (Basel)</source>. (<year>2023</year>) <volume>14</volume>(<issue>3</issue>):<fpage>545</fpage>. <pub-id pub-id-type="doi">10.3390/genes14030545</pub-id><pub-id pub-id-type="pmid">36980818</pub-id></mixed-citation></ref>
<ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>P</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Kim</surname> <given-names>SO</given-names></name> <name><surname>Radlanski</surname> <given-names>RJ</given-names></name> <name><surname>Butcher</surname> <given-names>K</given-names></name> <name><surname>Schneider</surname> <given-names>RA</given-names></name><etal/></person-group> <article-title>Ameloblast differentiation in the human developing tooth: effects of extracellular matrices</article-title>. <source>Matrix Biol</source>. (<year>2010</year>) <volume>29</volume>(<issue>5</issue>):<fpage>411</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2010.03.001</pub-id><pub-id pub-id-type="pmid">20211728</pub-id></mixed-citation></ref></ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/539058/overview">Syed Saad Bin Qasim</ext-link>, Roseman University of Health Sciences South Jordan Campus, United States</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1438036/overview">Florian Hermans</ext-link>, University of Hasselt, Belgium</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2333363/overview">Ammar Alghadeer</ext-link>, Imam Abdulrahman Bin Faisal University, Saudi Arabia</p></fn>
</fn-group>
</back>
</article>